Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for ... Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of oncology ...

Fintel reports that on April 4, 2025, Maxim Group downgraded their outlook for ... Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic ...

Maxim Group’s price objective would suggest a ... scPharmaceuticals Inc, a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.